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Abstract
Background: Concentration of care has been promoted as fostering superior outcomes. This study
was undertaken to determine if the concentration of care is occurring in Florida for a pancreaticoduo-
denectomy, and if so, is it having a salutary effect.
Methods: The data for a pancreaticoduodenectomy were obtained from the Florida Agency for Health
Care Administration for three 3-year periods:1992–1994, 2001–2003, 2010–2012; data were sorted by
surgeon volume of pancreaticoduodenectomy during these periods and correlated with post-operative
length of stay (LOS), in-hospital mortality and hospital charges (adjusted to 2012 dollars).
Results: Relative to 1992–1994, in 2010–2012 46% fewer surgeons performed 115% more pancreati-
coduodenectomies with significant reductions in LOS and in-hospital mortality, and higher charges
(P < 0.001 for each). From 1992–1994 to 2010–2012 there was an 18-fold increase in the number of
pancreaticoduodenectomies by surgeons completing ≥ 12 per year (n = 45 to n = 806, respectively).
During 2010–2012, the more frequently surgeons performed a pancreaticoduodenectomy, the shorter
LOS, the lower in-hospital mortality, the greater the likelihood of discharge home and the lower the
hospital charges (P < 0.03 for each).
Conclusions: Over the last 20 years, the concentration of care has occurred in Florida with substan-
tially fewer surgeons undertaking many more pancreaticoduodenectomies with dramatic improvements
in LOS and in-hospital mortality, albeit with increased hospital charges.
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Introduction
An analysis of centralization from the Netherlands that was
first initiated in 1994 and demonstrated a volume–mortality
relationship.1 The Leapfrog Group released a statement in 2000
projecting that as many 98 000 American deaths were caused
by medical errors.2 One of the proposed safety initiatives to
prevent medical errors recommended that patients should go
to high-volume hospitals for complex treatments. Since then,
centralization of complex care has been a steadily increasing
subject in the medical literature. Pancreatic resections are
among one of the ‘complex treatments’ recommended to be
carried out at high-volume centres. A pancreaticoduodenecto-
my is a formidable pancreatic resection that requires a sound
approach and technique. Many previous studies have demon-
strated a clear benefit for patients who undergo a pancreatico-
duodenectomy at a high-volume centre.3–9 As much as a 61%
decline in in-hospital mortality has been attributed to central-
ization of a pancreaticoduodenectomy.8
However, what does current practice reflect? Are trends
beginning to reflect what the Leapfrog criteria suggest? A study
in 2003 demonstrated that 77% of pancreaticoduodenectomies
were completed at low-volume institutions.10 A different study,
published in 2004, reported that 60% of pancreatic resections
were operated at low-volume hospitals.11 We have previously
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shown that pancreaticoduodenectomies were performed in
low-volume hospitals in Florida.3,4
Now, 13 years after the first Leapfrog statement was pub-
lished, an update on the volume-outcome relationship with a
pancreaticoduodenectomy is needed. As well, an update on our
previous reports on where pancreaticoduodenectomies are
undertaken and how the frequency with which surgeons per-
form a pancreaticodudoenectomy determines the length of stay
(LOS), hospital charges and in-hospital mortality seems
warranted. The purpose of this study was to determine if the
concentration of care for a pancreaticoduodenectomy was
occurring and, as well, we sought to determine if high-volume
surgeons achieve best results as would be purported by many
of these same studies. Our hypotheses in undertaking this
study were that a greater number of pancreaticoduodenecto-
mies are being done at high-volume centres by high-volume
surgeons (i.e. centralization of care was occurring) and that
this is positively impacting patient outcomes.
Patients and methods
The database for the State of Florida Agency for Healthcare
Administration (AHCA) was queried to identify all patients
who underwent a pancreaticoduodenectomy over three 3-year
periods 9 years apart: 1992–1994, 2001–2003 and 2010–2012.
The ICD-9 procedure code 57.2 was utilized to identify
patients whose principle procedure while hospitalized was a
pancreaticoduodenectomy.12 Where pancreaticoduodenecto-
mies were performed was determined by the physician (i.e.
surgeon) ID number. Surgeons were stratified by the number
of pancreaticoduodenectomies that they undertook over a
36-month period: one to three pancreaticoduodenectomies
(≤ 1 per year), four to nine pancreaticoduodenectomies (> 1
to ≤ 3 per year), 10–18 pancreaticoduodenectomies (> 3 to
≤ 6 per year), 19–36 pancreaticoduodenectomies (> 6 to ≤ 12
per year) and greater than 36 pancreaticoduodenectomies (≥12
per year). Leapfrog criteria designate hospitals at which 12 or
more pancreaticoduodenectomies are undertaken yearly as
‘high-volume’. This definition was applied to surgeons; there-
fore, high-volume surgeons were defined as surgeons who
undertook at least 36 pancreaticoduodenectomies within a
3-year span.13 Under a separate data analysis, very high-volume
surgeons were also identified. Very high-volume surgeons were
defined as surgeons that undertook more than 30 pancreatico-
duodenectomies per year. This volume was based on a paper
that identified that 31 pancreaticoduodenectomies per year was
the ideal number to reduce in-hospital mortality.14
In the years 1992–1994 and 2001–2003, up to 10 diagnoses
codes were collected in the AHCA database for each patient;
whereas in years 2010–2012, up to 30 diagnoses were collected
in the AHCA database. Thereby, to keep the number of diag-
noses analysed consistent, only the first 10 diagnoses codes
were evaluated in years 2010–2012 to determine the number
and variety of comorbidities. The following comorbidities were
tallied for each patient: Old Myocardial Infarction (ICD-9:
412), Diabetes (ICD-9 250), Chronic Obstructive Pulmonary
Disorder (ICD-9 496), Congestive Heart Failure (ICD-9 428),
Chronic Kidney Disease (ICD-9 585), Emphysema (ICD-9:
492), AIDS (ICD-9: 42), Cirrhosis (ICD-9: 571) and/or Periph-
eral Vascular Disease (ICD-9: 443).12 Older editions of ICD
coding were searched to ensure that ICD-9 codes were consis-
tent throughout the periods investigated. These comorbidities
were chosen from the list of comorbidities utilized to calculate
the Charlson Comorbidity Index.15
Data were collected and evaluated on post-operative LOS,
hospital charges and in-hospital mortality. Hospital charges
were adjusted to 2012 dollars according the Bureau of Labor
Statistics.16 The patients’ discharge statuses were identified as
‘discharged to home with self-care’, ‘home with home health
care’, ‘hospice’, ‘skilled nursing facility’, or ‘expired’. This was
collated by ‘discharge to home’ (regardless of with self-care or
with home healthcare) or ‘discharge to a facility’ (hospice or
skilled nursing facility). The discharge data were stratified by
whether the pancreaticoduodenectomy was performed by a
high-volume surgeon or a low-volume surgeon.
Data were maintained on a spreadsheet (Excel, Microsoft,
Redmond, WA, USA) and analysed using GraphPad InStat,
version 3.06 (GraphPad InStat, GraphPad Software, Inc, San
Diego, CA, USA). The mean data are presented where appro-
priate unless otherwise noted. Significance was accepted with
95% probability.
Results
A total of 3531 pancreaticoduodenectomies were completed over
the years 1992–1994, 2001–2003 and 2010–2012 (Table 1). From
1992–1994 through to 2010–2012, there was a significant decrease
(46% fewer) in the number of surgeons performing significantly
more (115% more) pancreaticoduodenectomies (Table 1).
In 1992–1994, 63% of the pancreaticoduodenectomies were
carried out by surgeons who were undertaking ≤ 1 per year,
whereas 6% of the pancreaticoduodenectomies were performed
by surgeons who undertook > 12 per year, and thereby met
the Leapfrog criteria for a ‘high-volume’ surgeon (Table 1). In
2001–2003, 30% of pancreaticoduodenectomies were done by
surgeons who were completing ≤ 1 per year and 29% of the
pancreaticoduodenectomies were performed by surgeons who
undertook > 12 per year (Table 1). In 2010–2012, 13% of the
pancreaticoduodenectomies were done by surgeons who were
undertaking ≤ 1 per year, whereas 51% of the pancreaticoduo-
denectomies were performed by surgeons who completed > 12
per year (Table 1). From 1992–1994 to 2010–2012, there was
an 18-fold increase in the number of pancreaticoduodenecto-
mies done by surgeons completing ≥ 12 per year (45–806)
whereas the number of surgeons undertaking ≥ 12 per year
increased from 1 to 11 (Table 1).
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As fewer surgeons did more pancreaticoduodenectomies
over the studied time periods, there were significant reductions
in LOS. In-hospital mortality significantly decreased from
1992–1994 to 2010–2012; this is a 64% decrease in in-hospital
mortality (P < 0.001). From 1992–1994 to 2001–2003, in-hospital
mortality decreased by 35% and from 2001–2003 to 2010–2012
in-hospital mortality decreased by 45%. Hospital charges sig-
nificantly increased by $40 495 from 1992–1994 to 2010–2012
(P < 0.001); this is a 44% increase from 1992–1994 to 2010–
2012. From 1992–1994 to 2001–2003, the increase was 11%
and from 2001–2003 to 2010–2012 the increase was 30%. Each
of these data points is depicted in Table 2 and Fig. 1. The table
is stratified by number of pancreaticoduodenectomies per
surgeon. The figure displays totals over the three different time
periods for each data point.
The variety and number of comorbidities, including the num-
ber of patients with major comorbidities, were not different across
the three time periods of 1992–1994, 2001–2003 and 2010–2012
(Table 3). As well, the presence of major comorbidities among the
patients was similar across all time periods and was independent
of surgeon volume across all time periods (Table 3).
Across all time periods, patients were more likely to be
discharged home than to a facility if they had their operation
performed by a high-volume surgeon compared with a low-
volume surgeon (Table 4, P < 0.001). In 1992–1994, the
patients that were operated on by a high volume surgeon (and
survived) were all discharged home.
A subgroup analysis was done for 2010–2012, the greater the
surgeon frequency of pancreaticoduodenectomy, the lower the
LOS; a linear regression of LOS versus surgeon frequency of
pancreaticoduodenectomy resulted in R² = 0.8565 with a nega-
tive, significantly non-zero slope (P = 0.029) (Fig. 2). Also in
2010–2012, an increased frequency of a pancreaticoduodenec-
tomy was associated with lower in-hospital mortality; a linear
regression of in-hospital mortality versus surgeon frequency of
a pancreaticoduodenectomy resulted in R² = 0.5329 with a
negative, significantly non-zero slope (P < 0.001) (Fig. 3). Fur-
thermore, in 2010–2012, hospital charges decreased with
increasing surgeon frequency of a pancreaticoduodenectomy; a
linear regression of hospital charges versus surgeon frequency
of pancreaticoduodenectomy resulted in R² = 0.6195 with a
negative, significantly non-zero slope (P < 0.001) (Fig. 4).
There were only two surgeons that met the criteria of the
very high-volume surgeon in 2010–2012. One surgeon met the
criteria in both the 2001–2003 and 2010–2012 periods.
Multivariate analysis revealed that in 1992–1994, increased
frequency contributed to patients having a lower acuity dis-
charge status, increased charges and a decreased LOS. In the
Table 1 The number of pancreaticoduodenectomies (PDs) 21 per
surgeon
PD per surgeon
over 36 months
Time
period
No.
surgeons
No.
PDs
over 36
months
1–3 (≤1 per year) 1992–1994 332 458
2001–2003 248 372
2010–2012 127 206
4–9 (>1 & ≤3 per year) 1992–1994 24 125
2001–2003 51 273
2010–2012 38 225
10–18 (>3 & ≤6 per year) 1992–1994 4 58
2001–2003 26 146
2010–2012 13 160
19–36 (>6 & ≤12 per year) 1992–1994 2 43
2001–2003 3 81
2010–2012 7 172
36–90 (12–30 per year) 1992–1994 1 45
2001–2003 6 248
2010–2012 11 534
>90 (>30 per year) 1992–1994 0 0
2001–2003 1 113
2010–2012 2 272
Total 1992–1994 363 729
2001–2003 334 1233
2010–2012 196 1569
Overall Total 3531
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Figure 1 Changes in outcomes and charges of a pancreaticoduodenectomy over 20 years. LOS, length of stay
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2001–2003 time period, surgeons that completed more pan-
creaticoduodenectomies were associated with a lower acuity
discharge status and had a decreased in-hospital mortality. The
frequency did not contribute to LOS or hospital charges. For
the most current time period (2010–2012), increased frequency
was related to lower hospital charges and a decreased in-hospi-
tal mortality.
Discussion
This study documents the long-term trends of centralization of
care for a pancreaticoduodenectomy, and that centralization is
yielding salutary benefits. In 2001 and 2008, using the state-
wide AHCA database from Florida, we reported that a pan-
creaticoduodenectomy was not centralized to major centres or
undertaken primarily by high-volume surgeons.3,4 Nonetheless,
when those reports were written, it was evident that patient
outcomes, measured by LOS and in-hospital mortality rates,
were superior with high-volume surgeons. Notably, between
those reports of time periods 1995–1997 and 2003–2005 overall
state-wide in-hospital mortality did not change and seemed
unacceptably high in each of the periods. Implied in these
reports was the notion that centralization of care would
improve outcomes with a pancreaticoduodenectomy. This
report shows that over the past 20 years in Florida, substan-
tially fewer surgeons are undertaking significantly more
pancreaticoduodenectomies with reductions in LOS and
in-hospital mortality, albeit with greater charges. Centralization
of care has occurred in Florida, and it seems to be continuing
with a salutary effect. As well, the more frequently surgeons
performed a pancreaticoduodenectomy in Florida in 2010–
2012 the lower the LOS, the lower the hospital charges, the
lower the in-hospital mortality and the higher the percentage
of patients discharged home. This again supports the concept
of centralization of care for a pancreaticoduodenectomy.
The patients in this study are representative of the popula-
tion in which a pancreaticoduodenectomy is performed across
America; there is nothing about these patients that is unique.
The data set used is complete and robust allowing for a
complete, thorough, and comprehensive analysis. The results
and conclusions drawn within can be taken with confidence.
This report involves over 3500 pancreaticoduodenectomies
undertaken in three different 3-year periods each 9 years
apart. From 1992–1994 to 2010–2012, less than half as many
surgeons were undertaking more than twice as many pancreati-
coduodenectomies. Now, for the first time, high-volume
Table 2 Surgeon volume, time period, post-operative length of stay (LOS), hospital charges and in-hospital mortality
No. PDs per surgeon
over 36 months
Period Post-op LOS (days)
median (mean  standard
deviation)
Hospital charges (2012 dollars)
median (mean  standard deviation)
In-hospital
mortality (%)
1–3
≤1 per year
1992–1994 16 (20  15.5) 99 644 (125 882  102091.4) 15.9
2001–2003 14 (18  12.6) 126 539 (158591  118119.0) 13.7
2010–2012 14 (18  15.2) 206 014 (264 991  207391.7) 9.2
4–9
>1 & ≤3 per year
1992–1994 15 (17  10.9) 86 112 (104 405  79602.8) 6.4
2001–2003 13 (16  10.3) 111 935 (140 473  88545.9) 8.4
2010–2012 13 (16  12.7) 163 789 (225 451  203748.1) 4.4
10–18
>3 & ≤6 per year
1992–1994 15 (18  11.5) 74 495 (97 566  85363.24) 6.9
2001–2003 12 (15  9.5) 129 468 (161 840  138467.7) 8.2
2010–2012 12 (15  10.7) 189 949 (225 259  170791.8) 8.1
19–36
>6 & ≤12 per year
1992–1994 17 (22  15.3) 72 496 (96 074  61187.8) 4.7
2001–2003 11 (17  21.0) 101 398 (148 404  145713.6) 9.9
2010–2012 9 (12  8.2) 93 514 (121 828  114409.3) 1.7
36–90
>12 & ≤30 per year
1992–1994 13 (19  13.9) 101 460 (161238  148582.1) 11.1
2001–2003 12 (14  8.9) 86 237 (113 748  90 956) 3.2
2010–2012 10 (13  9.9) 115 364 (151 364  115 015) 3.0
>90
>30 per year
1992–1994 N/A N/A N/A
2001–2003 10 (12  7.7) 88 238 (96 003  40 452) 0
2010–2012 9 (12  11) 121 342 (162 120  151 633) 3.3
Total 1992–1994 15 (20  14.4) 92 605 (120 317  100187.5) 12.6
2001–2003 12 (16  11.6) 102 947 (139 540  108889.1) 8.2
2010–2012 11 (14  11.5) 133 550 (183 104  162977.6) 4.5
PDs, pancreaticoduodenectomies.
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surgeons perform more than half of the pancreaticoduodenecto-
mies performed in Florida. With this change, there was a nota-
ble decrease in in-hospital mortality, as it decreased by more
than half. As well, post-operative LOS decreased by a median of
more than a quarter, more than 4 days. These improvements
were not a result of better patient selection, as there was no dif-
ference in the percentages of patients with major comorbidities
among the time periods studied. However, there was a ‘cost’ to
these significant improvements as total hospital charges, even
when adjusted to 2012 dollars, significantly increased.
There were dramatically more high-volume surgeons in
2010–2012 than in prior time periods. High-volume surgeons
did more pancreaticoduodenectomies, as we noted an 18-fold
increase in the pancreaticoduodenectomies undertaken by
high-volume surgeons. As expected, high-volume surgeons had
better clinical outcomes; however, they might be measured. If
a patient had their pancreaticoduodenectomy completed by a
high-volume surgeon, they were more likely to be discharged
home. Being discharged home probably reflects a host of issues
and seems a fair surrogate marker of quality of care, given that
the patients were similar among time periods for their comor-
bidities. Interestingly, the percentage being discharged to home
has declined from the 100% seen from 1992–1994 to 88% seen
in the most current time frame. This decrease in the percent-
age discharged to home most probably reflects surgeons’
attempt to reduce LOS and readmission rates, as well as the
higher prevalence of facilities (i.e. skilled nursing facilities,
rehabilitation centres, etc.).
Our data adds to the body of literature that supports the
concentration of care for pancreaticoduodenectomy. With the
dissemination of well-trained surgeons, this may not always
be true. For example, a carotid endarterectomy is an opera-
tion that was recently removed from the ‘complex treat-
ments’ recommended to be carried out at high-volume
institutions based on available data.17 While the same may
occur in the future for a pancreaticoduodenectomy, we are
not there yet as the concentration of care that has occurred
over the past 20 years has translated into real, definable and
a meaningful benefit for patients. Our data supports the redi-
rection of patients in need of a pancreatic resection to high-
volume centres. These data are not totally unique; a 2007
study out of Texas, which reviewed Texan Inpatient Data,
demonstrated that 58% of pancreaticoduodenectomies were
undertaken at facilities that undertook more than 10 resec-
tions per year.5 While, their in-hospital mortality was similar
to the in-hospital mortality obtained by high-volume sur-
geons in Florida in the most recent time span (3.3% versus
3.1%, respectively), 10 resections per hospital per year seem
to be on the low side.
This study provides the most current snapshot of the
centralization of care and demonstrates that the majority of
pancreatic resections are being done by high-volume surgeons
in high-volume centres. This centralization is associated with a
salutary decrease of in-hospital mortality across all patients in
the sample, primarily because of the impact of the large num-
ber of patients receiving care from higher volume surgeons.
Prior studies, including one from Gouma and colleagues pub-
lished in 2000, found there was a marked difference in the
post-operative death rate (16% versus 1.5%) between low-vol-
ume hospitals and high-volume hospitals, respectively.6
Certainly, high-volume hospitals have high-volume surgeons.
Notably, a high percentage of patients in that series were still
having resections by surgeons that performed less than five
pancreatic resections per year (including a pancreaticoduoden-
ectomy).6 When our group published in 2008, we demonstrated
Table 3 Pre-operative comorbidity status
Frequency of
pancreaticoduodenectomy
Time frame Percent
of patients
with a major
comorbidity
1–3 (≤1 per year) 1992–1994 35%
2001–2003 36%
2010–2012 31%
Overall 34%
4–9 (>1 & ≤3 per year) 1992–1994 26%
2001–2003 33%
2010–2012 40%
Overall 23%
10–18 (>3 & ≤6 per year) 1992–1994 24%
2001–2003 40%
2010–2012 31%
Overall 34%
19–36 (>6 & ≤12 per year) 1992–1994 40%
2001–2003 38%
2010–2012 34%
Overall 36%
>36 (>12 per year) 1992–1994 22%
2001–2003 33%
2010–2012 34%
Overall 33%
Table 4 Location to where patients were discharged to
Surgeon
volume
Discharge
status
1992–1994 2001–2003 2010–2012
High Discharged to
home
100% 94% 88%
High Discharged to
facility
0% 6% 12%
Low Discharged to
home
0% 83% 81%
Low Discharged to
facility
100% 17% 19%
HPB 2015, 17, 832–838 ª 2015 International Hepato-Pancreato-Biliary Association
836 HPB
that higher volume surgeons had a significantly lower in-hospi-
tal mortality, but it did not demonstrate an ‘across the board’
overall lower in-hospital mortality rate than the previously time
period analysed because so many patients were still cared for at
low-volume centres.4
The centralization of care for a pancreaticoduodenectomy
has possibly been influenced by the training of General Sur-
geons by accredited residency training programmes. Recently,
General Surgery trainees reported a median of 12 pancreatic
operations of all types and varieties during their entire 5-year
residency. That does not seem like much, particularly given
the potential variety of pancreatic operations over such an
extended period of time. This low level of experience gained
through residency training supports further specialized train-
ing programmes for surgeons interested in undertaking a
pancreaticoduodenectomy, and HPB surgery as a whole.18 It
follows that surgeons who complete such dedicated post-resi-
dency training would seek to focus on pancreatic surgery,
including a pancreaticoduodenectomy, further encouraging
centralization of care. Further, we plan to do a study that
analyses how educational centres are possibly influencing
referral patterns.
Centralization of care is dictated by referral patterns, both
physician-to-physician referrals and patient self-referrals. These
referrals have increased because of the plethora of information
on the need for a ‘high volume surgeon’ to perform the pancrea-
ticoduodenectomy. This thought is not uniquely ours.19 Also, we
have had patients travel from out of state to receive care from an
experienced pancreatic surgeon. For the most part, this was a
result of research done on the Internet. A study that looked at
online surveys of physicians found that 76% of individuals
viewed an online medical review prior to meeting with a physi-
cian had an impact on whom they saw.20 As the millennial
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generation ages, the percentage of those searching for informa-
tion on their physicians prior to seeking care should rise.
Centralization of care potentially leads to challenging patient
care scenarios, such as the operative candidate who cannot
transfer to a high-volume centre for a pancreatic resection. If a
pancreaticoduodenectomy is attempted only at high-volume
centres, then low-volume centres will have even lower volumes
going forward. This action would seemingly work to further
the schism between high-volume and low-volume centres.
Thus, how does our healthcare system guarantee access to care
for patients living in rural or low population density areas that
cannot relocate for care?
At what point is there a cap where frequency no longer dem-
onstrates benefits? Does the law of diminishing return apply to
pancreatic surgery? Arguably, the highest volume providers
would be taking on higher-risk patients or patients with more
advanced disease. Joseph et al. published that 31 pancreatic
resections per year provided the optimal outcome.14 Two of the
high volume surgeons in our practice undertook 117 and 155
operations in the most recent time period, averaging to 39 and
52 pancreaticoduodenectomies per year. Their volume helped
contribute to an in-hospital mortality rate of 3.1%, which is less
than half the national average of 6.6%.7 A systematic review of
the literature by van Heek and colleagues demonstrated that a
surgeon volume of a minimum of 24 pancreaticoduodenecto-
mies per year achieved less than 3% in-hospital mortality.1 If
there is such a cap, it is unknown.
It remains important to identify opportunities to improve
mortality, morbidity, LOS, hospital charges and access to care.
A pancreaticoduodenectomy, a complex and specialized opera-
tion, provides an opportunity to analyse patterns of centraliza-
tion of care. In Florida, a pancreaticoduodenectomy has been
undertaken in fewer centres by more high-volume surgeons
over the past 20 years, and a salutary benefit has been demon-
strated with this centralization of care.
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